Study of Hereditary Xerocytosis Features
Treatments studied
Part of Blood & lymphatic clinical trials.
This study looks at the features of hereditary xerocytosis, a rare condition where red blood cells lose water and become stiff. It aims to help doctors better understand this disease and how it affects patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with hereditary xerocytosis (a rare red blood cell condition).
- You must have health insurance (social security coverage).
- You (or your parent/guardian) must sign a consent form to join the study.
- You cannot have any other condition that causes red blood cell breakdown (like sickle cell disease or inherited spherocytosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the genes of people with a rare type of inherited anemia called congenital sideroblastic anemia, where the body has trouble making healthy red blood cells. It aims to find new genetic causes by looking at genes involved with the cell's energy centers (mitochondria).
This trial tests a drug called luspatercept to see if it can improve red blood cell production in people with certain rare inherited anemias. If you have one of these anemias and have low hemoglobin, this study might help you reduce or avoid blood transfusions.
This study looks for biological markers in the blood or eye samples of people with rare eye diseases compared to healthy volunteers. It aims to better understand and diagnose these conditions.
This trial aims to improve how doctors diagnose rare inherited anemias, including sickle cell disease and other conditions that destroy red blood cells. It may help if you have a confirmed or suspected diagnosis but need more clarity through advanced testing.
This study looks at how red blood cells work in people who have a related condition—or who have family members with one. It may help researchers understand causes of these diseases and improve future care.
This study looks at new ways to use routine blood test results to help diagnose hereditary spherocytosis, a condition where red blood cells are fragile. The goal is to make diagnosis easier and more accurate for children.
Hear when a new Phenotype trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.